Breaking News Instant updates and real-time market news.

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

11:01
09/19/17
09/19
11:01
09/19/17
11:01

NuVasive mentioned cautiously in short report from GlassHouse Research

Reference Link

NUVA NuVasive
$57.80

-0.68 (-1.16%)

08/28/17
08/28/17
DOWNGRADE

Underperform
NuVasive downgraded to Underperform at Needham
As previously reported, Needham analyst Mike Matson downgraded NuVasive (NUVA) to Underperform from Hold saying that his math indicates that consensus revenue estimates require an acceleration in its market share gains but NuVasive's rate of market share gain is more likely to decrease given the improving spine performance at Medtronic (MDT). Further, the analyst believes that slower revenue growth is likely to limit operating leverage putting consensus EPS estimates at risk as well. Matson expects NuVasive's revenue growth to approach the mid-single digits and its EPS growth to approach the mid-teens.
09/07/17
BTIG
09/07/17
INITIATION
BTIG
Buy
NuVasive initiated with a Buy at BTIG
BTIG analyst Ryan Zimmerman started coverage of NuVasive with an $82 price target and a Buy rating. The analyst says that the company's "innovative product offerings" have enabled its growth to exceed that of its market. The analyst notes that the company has taken steps to improve its operating profitability, and he thinks that the recent decline in the stock has created "a compelling entry point."
09/07/17
PIPR
09/07/17
NO CHANGE
PIPR
Overweight
Piper 'strongly' encourages buying NuVasive on recent pullback
Piper Jaffray analyst Matt O'Brien believes NuVasive's acquisition of Vertera, while small, is an "interesting technology/patent play for the long term." The analyst "strong" encourages investors take advantage of the recent pullback to start or build positions in the name. He keeps an Overweight rating on the shares with a $90 price target.
09/18/17
COWN
09/18/17
NO CHANGE
Target $83
COWN
Outperform
NuVasive shares reflect most investor concerns, says Cowen
Cowen analyst Joshua Jennings said NuVasive shares likely reflect most investor concerns regarding US spine volumes, insurers push-back, guidance, weather impact, and the CFO departure. Jennings expects investors to begin to focus on the LessRay system, new products, new salespeople, and new surgeon customers, which will drive a recovery in shares. The analyst rates NuVasive an Outperform with an $83 price target.

TODAY'S FREE FLY STORIES

14:55
09/19/18
09/19
14:55
09/19/18
14:55
Conference/Events
UBS consumer goods analyst to hold an analyst/industry conference call »

Consumer Goods/Softlines…

TLRY

Tilray

$261.68

106.69 (68.84%)

14:52
09/19/18
09/19
14:52
09/19/18
14:52
Hot Stocks
Breaking Hot Stocks news story on Tilray »

Tilray trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$141.62

-1.17 (-0.82%)

14:49
09/19/18
09/19
14:49
09/19/18
14:49
Options
Red Hat options imply 12.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

HKMPY

Hikma

$0.00

(0.00%)

14:47
09/19/18
09/19
14:47
09/19/18
14:47
Conference/Events
Hikma has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MS

Morgan Stanley

$49.09

1.22 (2.55%)

14:45
09/19/18
09/19
14:45
09/19/18
14:45
Options
Morgan Stanley call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 02

    Oct

FB

Facebook

$162.94

2.63 (1.64%)

14:42
09/19/18
09/19
14:42
09/19/18
14:42
Periodicals
Facebook user terms not yet in line with EU consumer laws, Reuters says »

Facebook may be slapped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

IPSEY

Ipsen

$0.00

(0.00%)

14:40
09/19/18
09/19
14:40
09/19/18
14:40
Conference/Events
Ipsen has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SIEN

Sientra

$23.85

-0.3 (-1.24%)

14:40
09/19/18
09/19
14:40
09/19/18
14:40
Hot Stocks
SEC charges Sientra, former CEO with misleading investors »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

14:35
09/19/18
09/19
14:35
09/19/18
14:35
General news
Fed Policy Outlook: by this time next week »

Fed Policy Outlook: by…

DRE

Duke Realty

$28.36

-0.35 (-1.22%)

14:29
09/19/18
09/19
14:29
09/19/18
14:29
Hot Stocks
Duke Realty VP Peter Harrington sells almost 17K shares »

Duke Realty VP Peter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXGBY

Hexagon AB

$0.00

(0.00%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Conference/Events
Hexagon AB management to meet with RBC Capital »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

WMB

Williams

$28.14

0.05 (0.18%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Hot Stocks
Williams requests FERC permission to place Atlantic Sunrise into full service »

Williams reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$4.93

0.675 (15.86%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Options
Neptune Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$162.44

5.8 (3.70%)

14:18
09/19/18
09/19
14:18
09/19/18
14:18
Recommendations
Alibaba analyst commentary  »

Stifel still confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/19/18
09/19
14:17
09/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$169.33

-6.1 (-3.48%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Periodicals
Spotify accused of ' fostering a negative work culture for women,' Verge says »

Music streaming company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$162.49

5.85 (3.73%)

14:13
09/19/18
09/19
14:13
09/19/18
14:13
Periodicals
Alibaba no longer plans to bring 1M jobs to U.S. in wake of trade war, CNBC says »

Alibaba founder and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SAFM

Sanderson Farms

$100.90

-2.04 (-1.98%)

14:09
09/19/18
09/19
14:09
09/19/18
14:09
Hot Stocks
Sanderson Farms reports on impact to operations from Hurricane Florence »

Sanderson Farms reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 06

    Nov

14:08
09/19/18
09/19
14:08
09/19/18
14:08
Conference/Events
RBC Capital internet analyst to hold a luncheon »

Internet Analyst Mahaney…

14:06
09/19/18
09/19
14:06
09/19/18
14:06
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

14:04
09/19/18
09/19
14:04
09/19/18
14:04
Conference/Events
RBC Capital biotech analysts to hold a group breakfast »

Biotech Gene Therapy…

CZR

Caesars

$10.90

0.1 (0.93%)

14:00
09/19/18
09/19
14:00
09/19/18
14:00
Options
Caesars option volume is 2X daily average and calls lead puts 10:1 »

Caesars option volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

13:51
09/19/18
09/19
13:51
09/19/18
13:51
Initiation
Elanco, Eli Lilly initiated  »

Elanco initiated with a…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

LFUS

Littelfuse

$204.06

-9.68 (-4.53%)

13:41
09/19/18
09/19
13:41
09/19/18
13:41
Recommendations
Littelfuse analyst commentary  »

Use weakness to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.